Authors
Ajai Chari, MD, is an expert in hematologic oncology who cares for patients at University of California San Francisco Health.
Mark F. Pyfer, MD, is a board-certified ophthalmic surgeon at Northern Ophthalmic Associates in Jenkintown, Pennsylvania. He is also on the volunteer teaching faculty and medical staff at Wills Eye Hospital and Thomas Jefferson University. This commentary represents his own personal opinion.
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Exploring Identity, Appearance Experiences Among Patients With Alopecia
5





